Does the PEMT rs7946 T/T genotype increase dietary choline need and raise homocysteine levels?

The relationship between the PEMT gene, choline metabolism, and homocysteine levels is a critical axis in personalized nutrition. While the mechanistic links between choline availability and homocysteine are well-supported, the specific impact of the PEMT rs7946 T/T genotype requires careful distinction from its variant counterparts.

Genetic influence on PEMT activity

The PEMT rs7946 polymorphism (V175M) is a primary determinant of endogenous phosphatidylcholine (PC) synthesis. However, the claim that the T/T genotype reduces synthesis is inconsistent with current genomic data:

• Enzymatic Activity: The T allele represents the high-activity, "wild-type" form of the phosphatidylethanolamine N-methyltransferase enzyme. Mechanistic studies show that the T/T genotype maintains structural stability and robust enzymatic function, whereas the minor A allele (Met) is a loss-of-function mutation that reduces activity by 30-50%.
• Phosphatidylcholine Synthesis: Individuals with the T/T genotype exhibit efficient de novo PC synthesis in the liver. It is actually the carriers of the A allele (A/A or A/T) who experience reduced synthesis and are thus at higher risk for choline deficiency-related issues like non-alcoholic fatty liver disease (NAFLD).

Choline requirements and homocysteine regulation

Although the T/T genotype is the "efficient" version of the enzyme, it remains central to determining dietary choline needs and downstream methyl donor availability:

• Dietary Dependency: Because PEMT provides an endogenous source of choline, any variation in this gene dictates how much "exogenous" (dietary) choline is required. While T/T individuals have higher internal production than A-allele carriers, they still rely on dietary intake to maintain total choline pools, especially during metabolic stress.
• The Betaine-BHMT Pathway: Choline is a direct precursor to betaine. When choline availability is limited—whether through diet or genetic partitioning—betaine levels drop. Betaine serves as the essential methyl donor for the enzyme betaine-homocysteine S-methyltransferase (BHMT).
• Homocysteine Remethylation: BHMT is responsible for up to 50% of homocysteine remethylation in the liver. If betaine is scarce due to low choline, BHMT activity is restricted, leading to an accumulation of homocysteine. Clinical models demonstrate that restoring choline or betaine levels effectively lowers plasma homocysteine by re-establishing this remethylation flux.

Bottom line

The PEMT rs7946 T/T genotype actually represents high endogenous synthesis of phosphatidylcholine, providing more protection against choline deficiency than the A-variant. However, the mechanistic link is valid: any state of low choline availability—regardless of genotype—will limit betaine production, impair BHMT-mediated remethylation, and lead to elevated homocysteine.